Literature DB >> 3119660

Pregnancies after IVF when high tonic LH is reduced by long-term treatment with GnRH agonists.

M C Macnamee1, C M Howles, R G Edwards.   

Abstract

Some patients show high output of urinary LH when superovulated with clomiphene citrate and HMG. Recent evidence has shown that this is detrimental to successful IVF. By the use of an GnRH analogue we have managed to ameliorate this condition and successfully establish pregnancy in these women. Further, the association between failure of IVF-ER and elevated levels of LH may explain the aetiology of some 'idiopathically' infertile couples.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3119660     DOI： 10.1093/oxfordjournals.humrep.a136590

Source DB:  PubMed          Journal:  Hum Reprod        ISSN： 0268-1161            Impact factor:   6.918


  9 in total

1.  The duration of pituitary suppression by means of intranasal gonadotropin hormone-releasing hormone analogue administration does not influence the ovarian response to gonadotropin stimulation and success rate in a gamete intrafallopian transfer (GIFT) program.

Authors:  V Remorgida; P Anserini; S Croce; M Costa; A Ferraiolo; A Centonze; G Gaggero; G L Capitanio
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-04

Review 2.  Safety of drugs used in assisted reproduction techniques.

Authors:  Talha Al-Shawaf; Ariel Zosmer; Martha Dirnfeld; Gedis Grudzinskas
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

3.  Reduced in vitro fertilization of human oocytes correlates with raised circulating FSH levels during ovarian stimulation in normogonadotropic women downregulated with GnRH-analogues.

Authors:  C Y Andersen; L G Westergaard; A G Byskov; K Erb
Journal:  J Assist Reprod Genet       Date:  1997-11       Impact factor: 3.412

Review 4.  Towards an Improved Understanding of the Effects of Elevated Progesterone Levels on Human Endometrial Receptivity and Oocyte/Embryo Quality during Assisted Reproductive Technologies.

Authors:  Nischelle R Kalakota; Lea C George; Sara S Morelli; Nataki C Douglas; Andy V Babwah
Journal:  Cells       Date:  2022-04-21       Impact factor: 7.666

5.  Pituitary down-regulation using leuprolide for the intensive ovulation management of poor prognosis patients having in vitro fertilization (IVF)-related treatments.

Authors:  J M Cummins; J M Yovich; W R Edirisinghe; J L Yovich
Journal:  J In Vitro Fert Embryo Transf       Date:  1989-12

6.  Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormone.

Authors:  A J Rutherford; R J Subak-Sharpe; K J Dawson; R A Margara; S Franks; R M Winston
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-25

7.  A randomized prospective study on the effect of short and long buserelin treatment in women with repeated unsuccessful in vitro fertilization (IVF) cycles due to inadequate ovarian response.

Authors:  M Dirnfeld; Y Gonen; A Lissak; S Goldman; M Koifman; Y Sorokin; H Abramovici
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-12

Review 8.  Clinical uses of gonadotropin-releasing hormone analogues.

Authors:  R F Casper
Journal:  CMAJ       Date:  1991-01-15       Impact factor: 8.262

9.  Selection of ovarian stimulation protocol is related to IVF treatment outcome in women 35 years of age and older.

Authors:  G Csemiczky; K Hagenfeldt; H Wramsby
Journal:  J Assist Reprod Genet       Date:  1994-10       Impact factor: 3.412
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.